The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
22 episodes
2 weeks ago
Craig Beavers and Kyle Fischer, PharmD, BCCP, MBA, discuss key late-breaking cardiovascular trials expected at the American Heart Association’s upcoming annual meeting, exploring their clinical relevance and implications for pharmacists.
All content for The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest is the property of The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Craig Beavers and Kyle Fischer, PharmD, BCCP, MBA, discuss key late-breaking cardiovascular trials expected at the American Heart Association’s upcoming annual meeting, exploring their clinical relevance and implications for pharmacists.
20: Inside AHA’s Late-Breaking Lipid Trials: The Rise of Oral PCSK9 Inhibition
The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
1 hour 2 minutes
4 weeks ago
20: Inside AHA’s Late-Breaking Lipid Trials: The Rise of Oral PCSK9 Inhibition
The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
Craig Beavers and Kyle Fischer, PharmD, BCCP, MBA, discuss key late-breaking cardiovascular trials expected at the American Heart Association’s upcoming annual meeting, exploring their clinical relevance and implications for pharmacists.
